Piedmont Investment Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,578
Closed -$1.12M 121
2020
Q1
$1.12M Buy
2,578
+221
+9% +$98.7K 0.04% 291
2019
Q4
$1.03M Sell
2,357
-218
-8% -$91.7K 0.04% 331
2019
Q3
$1.07M Sell
2,575
-89
-3% -$36.3K 0.04% 302
2019
Q2
$961K Buy
2,664
+1,118
+72% +$374K 0.04% 339
2019
Q1
$495K Sell
1,546
-1
-0.1% -$307 0.02% 532
2018
Q4
$438K Buy
1,547
+425
+38% +$128K 0.02% 510
2018
Q3
$359K Buy
+1,122
New +$358K 0.02% 687
2018
Q2
Sell
-3,454
Closed -$942K 2877
2018
Q1
$942K Buy
3,454
+172
+5% +$45.6K 0.03% 316
2017
Q4
$798K Sell
3,282
-202
-6% -$45.9K 0.02% 323
2017
Q3
$704K Buy
3,484
+7
+0.2% +$1.38K 0.02% 343
2017
Q2
$711K Buy
+3,477
New +$692K 0.02% 348

Other funds holding CHE

Piedmont Investment Advisors's CHE Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Chemed (CHE) in Q2 2020, closing a stake of 2,578 shares — an estimated $1.12M sold.

Piedmont Investment Advisors first reported a position in CHE in Q2 2017 and held it in 11 quarters. The position peaked at $1.12M in Q1 2020. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Chemed position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 2,578 Chemed shares in Q2 2020, an estimated $1.12M.
  • Piedmont Investment Advisors first reported a position in Chemed in Q2 2017 and held it in 11 quarters.
  • Piedmont Investment Advisors's Chemed position peaked at $1.12M in Q1 2020.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.